Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.

Kallergi G, Agelaki S, Kalykaki A, Stournaras C, Mavroudis D, Georgoulias V.

Breast Cancer Res. 2008;10(5):R80. doi: 10.1186/bcr2149. Epub 2008 Sep 29.

2.

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.

Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S.

Breast Cancer Res. 2008;10(5):R76. doi: 10.1186/bcr2143. Epub 2008 Sep 15.

3.

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.

Visvader JE, Lindeman GJ.

Nat Rev Cancer. 2008 Oct;8(10):755-68. doi: 10.1038/nrc2499. Epub 2008 Sep 11. Review.

PMID:
18784658
4.

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.

Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res Treat. 2009 Jun;115(3):581-90. doi: 10.1007/s10549-008-0143-x. Epub 2008 Aug 5.

PMID:
18679793
5.

Cancer stem cells in breast: current opinion and future challenges.

Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS.

Pathobiology. 2008;75(2):75-84. doi: 10.1159/000123845. Epub 2008 Jun 10. Review.

6.

Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Pantel K, Brakenhoff RH, Brandt B.

Nat Rev Cancer. 2008 May;8(5):329-40. doi: 10.1038/nrc2375. Review.

PMID:
18404148
7.

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G.

Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014.

8.

Systemic spread is an early step in breast cancer.

Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, Klein CA.

Cancer Cell. 2008 Jan;13(1):58-68. doi: 10.1016/j.ccr.2007.12.003.

9.
10.

Breast cancer stem cells: a case of mistaken identity?

Polyak K.

Stem Cell Rev. 2007 Jun;3(2):107-9. Review. No abstract available.

PMID:
17873341
11.

Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.

Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ, Weilbaecher KN, Fleming TP, Aft RL.

Clin Cancer Res. 2007 Sep 1;13(17):5001-9.

12.

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.

Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10069-74. Epub 2007 May 30.

13.

Molecular definition of breast tumor heterogeneity.

Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K.

Cancer Cell. 2007 Mar;11(3):259-73.

14.
15.

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF.

N Engl J Med. 2007 Jan 18;356(3):217-26.

16.

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR.

Breast Cancer Res. 2007;9(1):R4.

17.

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.

Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ.

Clin Cancer Res. 2006 Oct 1;12(19):5615-21.

18.

Cancer stem cells and metastasis: lethal seeds.

Wicha MS.

Clin Cancer Res. 2006 Oct 1;12(19):5606-7. No abstract available.

19.
20.

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.

Becker S, Becker-Pergola G, Wallwiener D, Solomayer EF, Fehm T.

Breast Cancer Res Treat. 2006 May;97(1):91-6. Epub 2005 Dec 1.

PMID:
16319975

Supplemental Content

Support Center